Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01887899
Other study ID # Plasticity in Alzheimer's
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 2013
Est. completion date December 2017

Study information

Verified date May 2021
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate whether the anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) in patients with dementia of the Alzheimer type (DAT) leads to an increase in cortical plasticity (change in motor evoked potentials (MEP) in mV).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria: - Right-handed according to the Oldfield Händigkeits inventory (lateralization index> 70) (1971) - Cognitive impairment, which corresponds to a mild to moderate DAT - No treatment with AChE inhibitors, or existing stable treatment with AChE inhibitors for over 3 months - No motor impairments relevant to everyday life - Age 50 to 80 years - Existing Insurance certificate - Existing informed consent Exclusion criteria: - Severe neurological / psychiatric or pre-existing internist conditions because additional cognitive deficits are expected - Epilepsy, epileptic seizure in medical history - Cognitive deficit (MMSE <20) - Depressive episode (Beck Depression Inventory (BDI)> 12) - intake of centrally active drugs <3 months, particularly acetylcholinesterase inhibitors - Pregnancy - Pacemaker (contraindication for MRI) - Other metal parts in the body (contraindication for MRI)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation

sham stimulation


Locations

Country Name City State
Germany Klinik und Poliklinik für Neurologie, Charité Universitätsmedizin Berlin Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary the anodal transcranial direct current stimulation over the primary motor cortex (M1) in patients with dementia of Alzheimer type (DAT) to investigate whether the anodal transcranial direct current stimulation over the primary motor cortex (M1) in patients with dementia of Alzheimer type (DAT) increases cortical plasticity (measured via motor evoked potentials) compared to a sham stimulation 1 week
Secondary tDCS effects on central cholinergic activity in patients with DAT to investigate whether the anodal transcranial direct current stimulation affect central cholinergic activity (measured via a TMS-protocol) in patients with dementia of Alzheimer type (DAT) compared to a sham stimulation 1 week
Secondary tDCS effects on learning tDCS-induced changes in learning success (performance in a motor learning paradigm in patients with DAT after tDCS vs. sham stimulation) 1 week
Secondary MR elastography Comparison of viscoelastic parameters in cerebral MR elastography in patients with DAT 1 week
Secondary genetic polymorphism, ApoE4 optional assessment of genetic Apo4 epsilon status for assessment of differences in cortical plasticity and elasticity between Apo4 epsilon positive and negative participants once